Metraipolis › archive › dc_8d1a0ffef0ce
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease — Europe PMC PMID:41088853
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41088853
- DOI
- 10.1002/alz.70763
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:09:53.489Z
- SHA-256 of the archived text
527935d4b6085b5fac4dc7807e91fca41ef5f59be3c1de014d61d8f652cf18d5- Stable URL of this page
https://metraipolis.com/documento/dc_8d1a0ffef0ce
How to cite
Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease — Europe PMC PMID:41088853 — Europe PMC (en), https://europepmc.org/article/MED/41088853 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d1a0ffef0ce (Metraipolis archive dc_8d1a0ffef0ce, sha256 527935d4b6085b5fac4dc7807e91fca41ef5f59be3c1de014d61d8f652cf18d5)
BibTeX
@misc{dc8d1a0ffef0ce,
title = {Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease — Europe PMC PMID:41088853},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41088853},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d1a0ffef0ce; sha256 527935d4b6085b5fac4dc7807e91fca41ef5f59be3c1de014d61d8f652cf18d5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41088853. Agents can read the archived copy with the MCP tool read_document.